Emerging Therapies:
1. Hepcludex/Bulevirtide
2. Lonafarnib
3. JNJ-3989
Key pharma players involved:
2. Eiger Biopharmaceuticals
3. Janssen Pharmaceuticals
Click here and download free sample pages of the report.
Table of contents:
1. Report Introduction
2. Hepatitis D
3. Hepatitis D Current Treatment Patterns
4. Hepatitis D – DelveInsight’s Analytical Perspective
5. Therapeutic Assessment
6. Hepatitis D Late Stage Products (Phase-III)
7. Hepatitis D Mid Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Hepatitis D Discontinued Products
13. Hepatitis D Product Profiles
14. Hepatitis D Key Companies
15. Hepatitis D Key Products
16. Dormant and Discontinued Products
17. Hepatitis D Unmet Needs
18. Hepatitis D Future Perspectives
19. Hepatitis D Analyst Review
20. Appendix
21. Report Methodology
Download our full report: https://www.delveinsight.com/report-store/hepatitis-d-pipeline-insight
About DelveInsightDelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Kritika RehaniEmail: Send EmailPhone: 9193216187Address:304 S. Jones Blvd #2432 City: Las VegasState: NevadaCountry: United StatesWebsite: https://www.delveinsight.com/